National Research CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
NRC Health filed an amendment to its 2025 Annual Report to provide required director and executive compensation disclosures.
NASDAQ
National Research Corporation (NRC Health) reported a decrease in 2025 revenue and operating income but anticipates growth in 2026 driven by record Total Recurring Contract Value and strategic initiatives.
NASDAQ
NRC Health's FY 2024 revenue decreased, and the company is undergoing a leadership transition with a new CEO appointed effective June 1, 2025.
NASDAQ
National Research Corporation's 10-K filing for the fiscal year ended December 31, 2023, outlines the company's financial results, operational strategies, and potential risks.